The latest guidelines on statin use, particularly from the US Preventive Services Task Force (USPSTF) and the American College of Cardiology/American Heart Association (ACC/AHA), offer nuanced advice for the prevention of cardiovascular disease (CVD) [1].
Statins are recommended primarily for individuals aged 40 to 75 with certain risk factors [2]. The USPSTF suggests statins for those with at least one CVD risk factor (such as diabetes, high blood pressure, smoking or high cholesterol) and a 10-year CVD event risk of 10% or higher [3].
However, the ACC/AHA guidelines are broader, considering statin therapy for individuals with a 10-year risk as low as 7.5% and incorporating additional factors like family history and specific health conditions to personalize treatment further.
Recent studies published in JAMA highlight that the USPSTF guidelines might not cover all individuals who could benefit from statins, particularly younger adults and those with diabetes, whose calculated risk might not meet the threshold despite their higher actual risk.
The ACC/AHA guidelines address this by recommending coronary artery calcium (CAC) scoring and other risk enhancers to stratify risk better and make more informed decisions about statin use.
Statins, known for their efficacy, work by lowering LDL cholesterol, thereby reducing the risk of heart attacks and strokes. They are widely recognized for their safety and are considered safe for long-term use, although potential side effects like muscle pain should be monitored.
This reassurance about their safety and effectiveness should give you confidence in considering statin therapy.
Deciding whether to take statins is a decision to be made with others [4]. It should involve a thorough discussion with your healthcare provider, considering your risk factors, health history and lifestyle.
This personalized approach, guided by your healthcare provider’s expertise, ensures that the benefits of statin therapy are maximized while minimizing unnecessary medication use. This emphasis on informed discussions should make you feel supported in your decision-making process.
[1] https://www.acc.org/latest-in-cardiology/articles/2022/10/04/13/38/comparing-guideline-recommendations-of-statin-use-for-the-primary-prevention-of-ascvd
[2] https://www.ncbi.nlm.nih.gov/books/NBK430940/
[3] https://jamanetwork.com/journals/jama/fullarticle/2795521
[4] https://www.mayoclinic.org/diseases-conditions/high-blood-cholesterol/in-depth/statins/art-20045772
